Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in cushing’s disease

Neuroendocrinology

Volumn 64, Issue 5, 1996, Pages 393-397

  Merola, Bartolomeo ^a   Longobardi, Salvatore ^a   Colao, Annamaria ^a   Di Somma, Carolina ^a   Ferone, Diego ^a   Di Rella, Francesca ^a   Pivonello, Rosario ^a   Covelli, Vito ^a   Annunziato, Lucio ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Clinical neuroendocrinology; Corticotropin; Corticotropin releasing hormone; Cushing s disease; Tumor necrosis factor

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADENOMA; ADULT; ARTICLE; BLOOD ANALYSIS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CULTURE MEDIUM; CUSHING DISEASE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; BETA-ENDORPHIN; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; PETROSAL SINUS SAMPLING; PITUITARY NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10244266353     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127142     Document Type: Article

References (27)

1. Beutler B, Milsarc IW, Cerami A: Cachectin/ tumor necrosis factor: Production, distribution, and metabolic phase in vivo, J Immunol 1985;135:3972-3977.
2. Bernardini R, Kamilaris RC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP: Interactions between tumor necrosis fac-tor-u, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat, Endocrinology 1990:126:2876-2881.
3. Gaillard RC, Tumill D, Sappino P, Muller AF: Tumor necrosis factor-a inhibits the hormonal response of the pituitary gland to the hypothalamic releasing factors, Endocrinology 1990: 127:101-106.
4. Oldfield EH, Doppman JL, Nientan LK, Chrousos GP, Miller DL, Katz DA, Cutler GB, Loriaux DL: Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome, N Engl J Med 1991:325:897-905.
5. Colao A, Merola B, Tripodi FS, Di Sarno A, Esposito V, Marzullo P, La Tessa G, Spaziante R, Lombardi G: Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: Comparison of mul-lihormonal assay, baseline multiple sampling and ACTH-relcasing hormone test, Horm Res 1993:40:209-216.
6. Merola B, Colao A, Rossi E, La Tessa G, Spaziante R, Lombardi G: Hormonal gradients between inferior petrosal sinuses in various pituitary diseases, Acta Endocrinol 1992:126: 419-424.
7. Colao A, Merola B, Boudouresque F, La Tessa G, Oliver C, Lombardi G: ACTH and P-endor-phin concentrations in the inferior petrosal sinuses in Cushing's disease and in other pituitary diseases, J Endocrinol Invest 1992:55:807-813.
8. Colao A, Merola B, Cataldi M, La Tessa G, Boudouresque F, Oliver C, Di Renzo GF, An-nunziato L, Lombardi G: Alpha-melanocyte stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease, Neurocndoerinologv 1993;358:227-233.
9. Colao A, Ferone D, Di Sarno A, Tripodi FS, Ccrbonc G, Marzullo P, Boudouresque F, Oliver C, Merola B, Lombardi G: Vasopressin levels in Cushing's disease: Inferior petrosal sinus assay, response to corticotrophin-relcasing hormone and comparison to patients without Cushing's disease, Clin Endocrinol 1996;in press.
10. Colao A, Merola B, Di Sarno A, Ferone D, Marzullo P, Cerbonc G, Tripodi FS, Boudouresque F, Oliver C, Lombardi G: Corticotropin-releasing hormone administration increases u-mclanocylc-stimulating hormone levels in the interior petrosal sinuses in a subset of patients with Cushing's disease, Horm Res 1996;in press.
11. Lombardi G, Merola B, Milctto P, Colao A, De Chiara G, laccarino V, Spaziante R, Di Renzo GF, Tagliartela M, Annunziato L: Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypo-physcal phelbography, Neuroendocrinology 1987;46:333-338.
12. Lombardi G, Merola B, Colao A, Spaziante R, La Tessa G, Annunziato L: Prolactin in the inferior petrosal sinuses, Lancet 1990:335:538.
13. Colao A, Merola B, Ferone D, Calabrese MR, Longobardi S, Spaziante R, Di Renzo GF, Annunziato L, Lombardi G: Effect of corticotro-phin-rclcasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies, Eur J Endocrinol 1994; 131:14-19.
14. Imura H, Fukata J: Endocrine-paracrine interaction in communication between the immune and endocrine systems: Activation of the hypothalamic-pituitary-adrenal axis in inflammation, Eur J Endocrinol 1994;130:32-37.
15. Sherry B, Cerami A: Cachcctin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses, J Cell Biol 1988;107:1269-1277.
16. Blalock JE: A molecular basis for bidirectional communication between the immune and neuroendocrine systems, Physiol Rev 1989:69:1-32.
17. Ader R, Cohen N, Fcltcn D: Psychoneuroimmunology: Interactions between the nervous system and the immune system, Lancet 1995; 345:99-103.
18. Celik I, Akalin S, Erbas T: Serum levels of interleukin 6 and tumor necrosis factor-a in hyperthyroid patients before and after propylthiouracil treatment, Eur J Endocrinol 1995: 132:668-672.
19. Koenig JI, Snow K, Clark BD, Toni R, Cannon JC, Snow AR, Dinarcllo CA, Reichlin S, Lee SL, Lcchan RM: Intrinsic pituitary interlcukin-lp, is induced by bacterial lipopolysaccharidc, Endocrinology 1990:126:3053-3058.
20. Gatti S, Bartlai T: Induction of tumor necrosis factor-a mRNA in the brain after peripheral endotoxin treatment comparison with interleu-kin-l family and interleukin-6. Brain Res 1993; 624:292-294.
21. Sharp BM, Malta SG, Peterson PK, Newton R, Chao C, McAllen K: Tumor necrosis factor-a is a potent ACTH Secrctagoguc: Comparison to Interleukin-1. Endocrinology 1990:124:3131-3133.
22. Gaillard RC, Tumill D, Sappino P, Muller AF: Tumor necrosis facotr-a inhibits the hormonal response of the pituitary gland to hypothalamic releasing factor, Endocrinology 1990:127:101-106.
23. Said SL Porter JC: Vasoactive intestinal polypeptide: release into hvpophvscal portal blood, Life Sci 1978;24:227-230.
24. Gibbs DM: High concentrations of oxytocin in hypophysial portal plasma, Endocrinology 1984;l 14:1216-1218.
25. Smith EM, Morrill AC, Meyer WJ III, Blalock JE: Corticotropin releasing factor induction of lcucocyte-derived immunoreactive ACTH and endorphins, Nature 1986:321:881-887.
26. Meyer WJ III, Smith EM, Richards GE, Caval-lo A, Morrill AC, Blalock JE: In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH deficient individuals, J Clin Endocrinol Metab 1987;64:98-105.
27. Arzt E, Burie R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK: Interleukin involvement in anterior pituitary cell growth regulation: Effects of IL-2 and IL-6. Endocrinology 1993; 132:459-467.